PPIs and anti-TNF in patients with IBD: a forbidden combination?

Gut. 2021 Dec;70(12):2397-2398. doi: 10.1136/gutjnl-2021-324040. Epub 2021 Jan 29.

Judith Wellens^{1

2}, João Sabino^{3

2

4}, Séverine Vermeire^{2

4}

¹ Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium Judith.wellens@kuleuven.be.
² Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium.
³ Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium.
⁴ Department of Chronic Diseases Metabolism and Ageing, KU Leuven University Hospitals Leuven Campus Gasthuisberg, Leuven, Flanders, Belgium.

No abstract available

Keywords: IBD; IBD clinical; adverse drug reactions.

Publication types